SEARCH

SEARCH BY CITATION

References

  • 1
    Kapp A. Atopic dermatitis – the skin manifestation of atopy. Clin Exp Allergy 1995;25:210219.
  • 2
    Werfel T & Kapp A. Environmental and other major provocation factors in atopic dermatitis. Allergy 1998;53:731739.
  • 3
    Darsow U, Vieluf D, Ring J for the Atopy Patch Test Study Group. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. J Am Acad Dermatol 1999;40:187193.
  • 4
    Gondo A & Saeki NTY. Challenge reactions in atopic dermatitis after percutaneous entry of mite allergen. Br J Dermatol 1986;115:485493.
  • 5
    Wistokat-Wuelfing A, Schmidt P, Darsow U, Ring J, Kapp A, Werfel T. Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis. Clin Exp Allergy 1999;29:513521.DOI: 10.1046/j.1365-2222.1999.00510.x
  • 6
    Bruijnzeel PL, Kuijper PH, Kapp A, Warringa RA, Betz S, Bruijnzeel-Koomen CA. The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis. Clin Exp Allergy 1993;23:97109.
  • 7
    Tanaka Y, Anan S, Yoshida H. Immunohistochemical studies in mite-induced patch test site in atopic dermatitis. J Dermatol Sci 1990;1:361368.
  • 8
    Bieber T, De La Salle H, Wollenberg A, et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FcεRI). J Exp Med 1992;175:12851290.
  • 9
    Mudde GC, Von Reijsen FC, Boland GJ, Gast GC, Bruijnzeel PL, Bruijnzeel-Koomen CA. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990;69:335341.
  • 10
    Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992;89:801810.
  • 11
    Van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, et al. Skin derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992;90:184193.
  • 12
    Werfel T, Morita A, Grewe M, Renz H, Wahn U, Krutmann J, et al. Allergen-specificity of skin-infiltrating T-cells is not restricted to a type 2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 1996;107:871876.
  • 13
    Reekers R, Schmidt P, Kapp A, Werfel T. Evidence of a lymphocyte response to birch pollen related food antigens in atopic dermatitis. J Allergy Clin Immunol 1999;104:466472.
  • 14
    Werfel T, Ahlers G, Schmidt P, Boeker M, Kapp A. Detection of a κ-casein specific lymphocyte response in milk-responsive atopic dermatitis. Clin Exp Allergy 1996;26:13801386.
  • 15
    Werfel T, Ahlers G, Schmidt P, Boeker M, Kapp A, Neumann C. Milk-responsive atopic dermatitis is associated with a casein-specific lymphocyte response in adolescent and adult patients. J Allergy Clin Immunol 1997;99:124133.
  • 16
    Santamaria-Babi LF, Picker LJ, Perez-Soler MT, et al. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 1995;181:19351940.
  • 17
    Grewe M, Gyufko K, Schöpf E, Krutmann J. Lesional expression of interferon-γ in atopic eczema. Lancet 1994;343:2526.
  • 18
    Thepen T, Langeveld-Wiltschut EG, Van Reijsen FC, et al. Bi-phasic response against aeroallergen in atopic dermatitis showing a switch from initial TH2 response into a TH1 response in situ. J Allergy Clin Immunol 1996;97:828837.
  • 19
    Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993;167:9971002.
  • 20
    Fleischer B, Gerardy-Schahn R, Metzroth B, Carrel S, Gerlach D, Köhler W. An evolutionary conserved mechanism of T cell activation by microbial toxins. J Immunol 1991;146:1117.
  • 21
    Kappler J, Hermann K, Clements J, Marrack P. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med 1992;175:387396.
  • 22
    Mollick JA, McMasters RL, Grossmann D, Rich RR. Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity. J Exp Med 1993;177:283293.
  • 23
    Carlsson R, Fischer H, Sjögren HO. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol 1988;140:24842478.
  • 24
    Miethke T, Wahl C, Heeg K, Wagner H. Superantigens: the paradox of T-cell activation versus inactivation. Int Arch Allergy Immunol 1995;106:37.
  • 25
    Renno T, Attinger A, Locatelli S, Bakker T, Vacheron S, MacDonald HR. Cutting edge: apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo. J Immunol 1999;162:63126315.
  • 26
    Aly R. Bacteriology of atopic dermatitis. Acta Dermatol Venereol (Stockh) 1980;Suppl 92:1618.
  • 27
    Hauser C, Wüthrich B, Matter L, Wilhelm JA, Sonnabend W, Schopfer K. Staphylococcus aureus skin colonization in atopic dermatitis. Dermatologica 1985;170:3539.
  • 28
    Leung DYM, Harbeck R, Bina P, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. J Clin Invest 1993;92:13741380.
  • 29
    Leyden JE, Marples RR, Kligmann AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525530.
  • 30
    Monti G, Tonetto P, Mostert M, Oggero R. Staphylococcus aureus skin colonization in infants with atopic dermatitis. Dermatology 1996;193:8387.
  • 31
    Williams REA, Gibson AG, Aitchison TC, Lever R, Mackie RM. Assessment of contact plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol 1990;123:493501.
  • 32
    Cole GW & Silverberg NL. The adherence of Staphylococcus aureus to human corneocytes. Arch Dermatol 1986;122:166169.
  • 33
    Feingold DS. Bacterial adherence, colonization, and pathogenicity. Arch Dermatol 1986;122:161163.
  • 34
    Morishita Y, Tada J, Sato A, et al. Possible influences of Staphylococcus aureus on atopic dermatitis – the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy 1999;29:11101117.DOI: 10.1046/j.1365-2222.1999.00593.x
  • 35
    Milller SJ, Aly R, Shinefeld HR, Elias PM. In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 1988;124:209215.
  • 36
    Williams REA, Vowels BR, Honig PJ, Leyden JJ. S. aureus isolation from the lesions, the hands, and the anterior nares of patients with atopic dermatitis. Pediatr Dermatol 1998;15:194198.
  • 37
    Bunikowski R, Mielke M, Skarabis H, et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000;105:814819.
  • 38
    Akiyama H, Toi Y, Kanzaki H, Tada J, Arata J. Prevalence of producers of enterotoxins and the toxic shock syndrome toxin-1 among Staphylococcus aureus strains isolated from atopic dermatitis lesions. Arch Dermatol Res 1996;288:418420.DOI: 10.1007/s004030050075
  • 39
    McFadden JP, Noble WC, Camp RDR. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 2000;128:631632.
  • 40
    Nomura I, Tanaka K, Tomita H, et al. Evaluation of staphylococcal exotoxin and its specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol 1999;104:441446.
  • 41
    Bunikowski R, Mielke M, Skarabis H, et al. Prevalence and role of serum IgE antibodies to S. aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 1999;103:119124.
  • 42
    Strange P, Lone S, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996;132:2733.
  • 43
    Saloga J, Enk AH, Becker D, et al. Modulation of contact sensitivity responses by bacterial superantigen. J Invest Dermatol 1995;105:220224.
  • 44
    Saloga J, Leung DY, Reardon C, Giorno R, Born W, Gelfand EW. Cutaneous exposure to the superantigen staphylococcal enterotoxin B elicits a T-cell-dependent response. J Invest Dermatol 1996;106:982988.
  • 45
    Hofer MF, Lester MR, Schlievert PM, Leung DYM. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin Exp Allergy 1995;25:12181227.
  • 46
    Herz U, Schnoy N, Borelli S, et al. A human-SCID mouse model for allergic immune responses: bacterial superantigen enhances skin inflammation and suppresses IgE production. J Invest Dermatol 1998;110:224231.DOI: 10.1046/j.1523-1747.1998.00119.x
  • 47
    Strickland I, Hauk PJ, Trumble A, Picker LJ, Leung DY. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol 1999;112:249253.DOI: 10.1046/j.1523-1747.1999.00502.x
  • 48
    Torres MJ, Gonzales FJ, Corza JL, et al. Circulating CLA+ lymphocytes from children with atopic dermatitis contain an increased percentage of cells bearing staphylococcal-related T-cell receptor variable segments. Clin Exp Allergy 1998;28:12641272.
  • 49
    Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995;181:747753.
  • 50
    Ha SJ, Lee HJ, Byun DG, Kim JW. Expression of T cell receptor Vb chains in lesional skin of atopic dermatitis. Acta Dermatol Venereol (Stockh) 1998;78:424427.
  • 51
    Neuber K, Löliger C, Köhler I, Ring J. Preferential expression of T-cells receptor Vβ-chains in atopic eczema. Acta Dermatol Venereol (Stockh) 1996;76:214218.
  • 52
    Skov L, Olsen JV, Giorno R, Schlievert PM, Baadsgaard O, Leung DYM. Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. J Allergy Clin Immunol 2000;105:820826.
  • 53
    Zöllner TM, Wichelhaus TA, Hartung A, et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000;30:9941000.DOI: 10.1046/j.1365-2222.2000.00848.x
  • 54
    Breuer K, Wittmann M, Bösche B, Kapp A, Werfel T. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 2000;55:551555.
  • 55
    Campbell DE & Kemp AS. Production of antibodies to staphylococcal superantigens in atopic dermatitis. Arch Dis Child 1998;79:400404.
  • 56
    Akdis CA, Akdis M, Simon D, et al. T cells and T cell-derived cytokines as pathogenic factors in the non-allergic form of atopic dermatitis. J Invest Dermatol 1999;113:628634.DOI: 10.1046/j.1523-1747.1999.00720.x
  • 57
    Strange P, Skov L, Baadsgaard O. Interferon gamma-treated keratinocytes activate T cells in the presence of superantigens: involvement of major histocompatibility complex class II molecules. J Invest Dermatol 1994;102:150154.
  • 58
    Tokura Y, Yagi J, O'Malley M, et al. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class-II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 1994;102:3138.
  • 59
    Wakita H, Tokura Y, Furukawa F, Takigawa M. Staphylococcal enterotoxin B upregulates expression of ICAM-1 molecules on IFN-γ-treated keratinocytes and keratinocyte cell lines. J Invest Dermatol 1995;105:536542.
  • 60
    Matsunaga T, Katayama I, Yokozeki H, Nishioka K. Superantigen-induced cytokine expression in organ-cultured human skin. J Dermatol Sci 1996;11:104110.DOI: 10.1016/0923-1811(95)00426-2
  • 61
    Ezepchuk YV, Leung DYM, Middleton MH, Bina P, Reiser R, Norris DA. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-α from human keratinocytes. J Invest Dermatol 1996;107:603609.
  • 62
    Skov L, Olsen JV, Ramm M, Baadsgaard O. Superantigen staphylococcal enterotoxin B induces release of IL-1β in human epidermis. Acta Dermatol Venereol (Stockh) 2000;80:1718.
  • 63
    Bratton DL, May KR, Kailey JM, Doherty DE, Leung DYM. Staphylococcal toxic shock syndrome toxin-1 inhibits monocyte apoptosis. J Allergy Clin Immunol 1999;103:895900.
  • 63a. 
    Wedi B, Wieczorek D, Stuukee T, Kapp A. Pre-inflammatory effects of staphylococcal exotoxins on eosinophils: inhibition of apoptosis and modulation of cell surface antigen. Allergy 2001;56 Suppl 68:356.
  • 64
    Motala C, Potter PC, Weinberg EG, Malherbe D, Hughes J. Anti-Staphylococcus aureus-specific IgE in atopic dermatitis. J Allergy Clin Immunol 1978;78:583589.
  • 65
    Gabrielsen TO & Brandtzaeg P. Enzyme-linked immunosorbent assay (ELISA) for isotype-specific quantification of antibodies to Staphylococcus aureus in patients with atopic dermatitis. Acta Dermatol Venereol (Stockh) 1985;114:6166.
  • 66
    Kapp A & Schöpf E. Spezifisches IgE gegen Staphylococcus aureus bei Patienten mit atopischer Dermatitis. Hautarzt 1989;40:1922.
  • 67
    Neuber C & König W. Effects of Staphylococcus aureus cell wall products (teichoic acid, peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgG) synthesis and CD23 expression in patients with atopic dermatitis. Immunology 1992;75:2328.
  • 68
    Higaki Y, Hauser C, Rilliet A, Saurat JH. Increased in vitro cell-mediated immune response to staphylococcal antigens in atopic dermatitis. J Am Acad Dermatol 1986;15:12041209.
  • 69
    Jahreis A, Beckheinrich P, Haustein UF. Effects of two novel cationic staphylococcal proteins (NP-tase and p70) and enterotoxin B on IgE synthesis and interleukin-4 and interferon-γ production in patients with atopic dermatitis. Br J Dermatol 2000;142:680687.DOI: 10.1046/j.1365-2133.2000.03412.x
  • 70
    Lever R, Hadley K, Downey S, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189198.
  • 71
    Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992;27:2934.
  • 72
    Brockow K, Grabenhorst P, Åbeck D, et al. Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus aureus-colonized atopic eczema. Dermatology 1999;199:231236.
  • 73
    Boguniewicz M, Sampson HA, Bina P, et al. Effects of antibiotic treatment on S. aureus colonization in atopic dermatitis. J Allergy Clin Immunol 1999;103:S179.
  • 74
    Ewing CI, Ashcroft C, Gibbs ACC, Jones GA, Connor PJ, David TJ. Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol 1998;138:10221029.